One participant with a history of depression experienced a new episode of depression during the study with an associated increase in PHQ-9 of from 15 to 20 points despite an initial sense of increased resilience
Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, said John Sharretts, MD, director of the FDAs Division of Diabetes, Lipid Disorders, and Obesity
The other overhauls how your entire body processes food, hunger, and satiety
P., Doan, B
And remember: as a SemaPen subscriber, you have direct access to expert support from our team
Results We find high interest around GLP-1 RAs, with a total of 168 topics and 33 groups focused on the GLP-1 RA experience with weight loss, comparison of side effects between differing GLP-1 RAs and alternate therapies, issues with GLP-1 RA access and supply, and the positive psychological benefits of GLP-1 RAs and associated weight loss